CEDARHURST, N.Y., Jan. 29, 2019 (GLOBE NEWSWIRE) -- Kuznicki Law PLLC notifies investors that a class action has commenced on behalf of shareholders who purchased American Depositary Shares of Loma Negra Compañía Industrial Argentina Sociedad Anónima (LOMA) pursuant to the November 2017 Initial Public Offering. Shareholders who purchased shares in these companies during the dates listed below are encouraged to contact the firm regarding possible appointment as lead plaintiff and a preliminary estimate of their recoverable losses.
If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in the respective securities during the class periods. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No classes have yet been certified in the actions below. Appointment as lead plaintiff is not required to partake in any recovery.
Loma Negra Compañía Industrial Argentina Sociedad Anónima (LOMA)
The complaint alleges that the Registration Statement contained untrue statements of material fact and omitted material facts. In particular, the Registration Statement downplayed and misrepresented Loma Negra’s exposure to a massive, ongoing corruption scandal engulfing its majority owner, InterCement Participações S.A. The Registration Statement further misrepresented a purported increased demand for Loma Negra’s cement and other products as a result of economic growth and government funding for public works projects in Argentina, as well as the purported benefits to Loma Negra from that increased demand. The Registration Statement also misrepresented events and trends in the Argentinian economy, as well as Loma Negra’s exposure thereto.
Shareholders may find more information at https://kseclaw.com/securities/loma-negra-compania-industrial-argentina-sociedad-anonima-ads-loss-form/?wire=3
Teladoc Health, Inc. (TDOC)
A class action has commenced on behalf of shareholders in Teladoc Health, Inc. who purchased shares between March 3, 2016 and December 5, 2018. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Executive Vice President and Chief Operating Officer Mark Hirschhorn was engaged in an inappropriate sexual relationship with a subordinate; (ii) Hirschhorn and this subordinate engaged in insider trading to provide themselves with undue benefits; (iii) Hirschhorn caused the subordinate to receive promotions for which she was unqualified, thereby negatively impacting the Company’s operations; (iv) the Company’s enforcement of its own purported employment and trading policies were inadequate to prevent the foregoing conduct; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.
Shareholders may find more information at https://kseclaw.com/securities/teladoc-health-inc/?wire=3
Allergan plc (AGN)
A class action has commenced on behalf of shareholders in Allergan plc who purchased shares between May 9, 2017 and December 19, 2018. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: During the Class Period, and unbeknownst to investors, Allergan misled investors regarding various “pharma and device approvals” and concealed the fact that the Company’s CE Mark for its textured breast implants and tissue expanders was expiring in Europe. On December 19, 2018, the Company announced that, following a compulsory recall request from Agence Nationale de Sécurité du Médicament (“ANSM”), the French regulatory authority, the Company had suspended the sale of these products and that it was withdrawing all remaining supplies from European markets. The suspension of sales stemmed directly from the expiration of the company's CE Mark for these products, and the stock price fell drastically following the news.
Shareholders may find more information at https://kseclaw.com/securities/allergan-plc/?wire=3
DXC Technology Company (DXC)
A class action has commenced on behalf of shareholders in DXC Technology Company who purchased shares between February 8, 2018 and November 6, 2018. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (a) the Company had changed or planned to change the operations of its sales teams, deploying generalized sales teams as opposed to the specialized teams that were better capable of delivering specialized services to its clients; (b) the Company’s workforce optimization strategy of sharply reducing staff while reducing costs was resulting in a shortage of sales personnel who could execute on demand for services, thereby risking and ultimately losing sales and revenue opportunities; (c) in light of the above, the Company’s revenue and financial performance guidance for the fiscal year 2019 and its reaffirmation of the guidance during the Class Period was without a reasonable basis.
Shareholders may find more information at https://kseclaw.com/securities/dxc-technology-company/?wire=3
Kuznicki Law PLLC is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock.
Kuznicki Law PLLC
Daniel Kuznicki, Esq.
445 Central Avenue, Suite 334
Cedarhurst, NY 11516
Phone: (347) 696-1134
Cell: (347) 690-0692
Fax: (347) 348-0967